Soolantra (ivermectin) is a brand-name drug that’s prescribed for rosacea in adults. Soolantra comes as a topical cream that’s typically applied once per day. Soolantra belongs to a drug class called ...

Soolantra (ivermectin) is a brand-name topical cream that’s prescribed for rosacea. As with other drugs, Soolantra can cause side effects, such as skin irritation. Soolantra can cause certain side ...

Please provide your email address to receive an email when new articles are posted on . Galderma Laboratories announced that the U.S. Food and Drug Administration has approved Soolantra Cream for once ...

Once-Daily Topical Cream for Rosacea Approved Galderma announced that the Food and Drug Administration (FDA) has approved Soolantra (ivermectin) Cream for the topical treatment of inflammatory lesions ...

FT. WORTH, Texas--(BUSINESS WIRE)--Galderma Laboratories, L.P. today announced that Soolantra® (ivermectin) Cream, 1% – a once-daily, antibiotic-free, prescription topical treatment for rosacea – is ...

Galderma announced the availability of Soolantra (ivermectin) Cream for the the treatment of rosacea. Soolantra Cream was approved in December 2014 by the Food and Drug Administration (FDA).

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced the U.S. launch of its generic ...

Galderma, a global specialty pharmaceutical company focused on dermatology, announced today a positive outcome of the European Decentralised Procedure (DCP) for SOOLANTRA ® (ivermectin) Cream 10mg/g ...

U.S. retailer Best Buy is weighing the expansion of its India headcount to primarily add more digital and technology roles, Nithya Subramanian, senior director, data & AI COE, told Reuters.

Judges loved this impactful campaign for Galderma’s new rosacea treatment Soolantra. “Great stopping power and relationship to the key product benefit,” said one judge. “Effective, cost-effective and ...

Meta Platforms forecast third-quarter revenue well above analysts' estimates on Wednesday, as artificial intelligence once more powered its core advertising business, sending its shares soaring 11% in ...